SUMMARY The role of Atrial Fibrillation (AF) as a precursor of stroke was examined in the Fram ingham cohort based on 30 years of follow-up during which time 501 strokes occurred. There were 59 persons who sustained stroke in association with AF excluding those with rheumatic heart disease. AF increased the risk of stroke five-fold and the excess risk was found to be independent of the frequently associated cardiac failure and coronary heart disease. The contribution of AF to stroke risk was also at least as powerful as that of the other cardiovascular precursors.
CHRONIC AF unassociated with rheumatic heart dis ease (RHD) has been found to be related to an in creased incidence of stroke. Prospective eidemiologic study at Framingham, MA discloses stroke incidence following chronic nonrheumatic AF is increased more than five-fold even after age, sex, and the frequently associated hypertension is taken into account. 1 Some have suggested that paroxysmal, intermittent and recent-onset AF is particularly hazardous with an excess of stroke occurring in this group. 2 From the standpoint of prevention, clarification of this point is essential. We have studied the development of stroke in relation to duration of AF in a general population sample followed prospectively since 1950, comprising 30 years of follow-up. The purpose of the present re port is to examine the time course of this threat of stroke, the likelihood and temporal pattern of stroke recurrences and case-fatality rates.
Methods
We evaluated the development of stroke in 5184 men and women, aged 30 to 62, and free of stroke at entry followed for 30 years. Sampling procedure, cri teria, and methods of examination have been described elsewhere. 3 Subjects were examined every two years. Follow-up was satisfactory with 81 % taking all possi ble examinations and less than five percent of the origi nal cohort lost to mortality follow-up.
On each of the 16 biennial examinations, the subject was routinely questioned by a physician concerning habits, medications, and illnesses during the preceding two years. Physical examination and laboratory stud ies were made, and details surrounding all interim ill nesses were sought. For stroke, including transient ischemic attacks (TIAs), surveillance was maintained by daily monitoring of all admissions to the only gen eral hospital in town. If stroke was suspected, the patient was seen in the hospital by the study neurolo gist. Neurologic symptoms or signs noted by the study physician at biennial examination were followed by a detailed evaluation in the neurology clinic. The cir cumstances surrounding all illnesses and the death of each study subject were also sought by scrutiny of all available medical information, including hospital and physician records and post-mortem data. Prospective ly, all data were reviewed by a panel of physicians to determine if minimal criteria were met for the diagno sis of the diseases under study and to determine the underlying cause of death. A neurologist has partici pated in reviews of suspected stroke cases for the past 20 years. ioT stroke or TIA was suspected. Most had lumbar punc ture, brain scan, EEG and skull radiographs prior to CT scan availability. In recent years at least one CT scan has been done soon after admission on most sub jects with stroke or TIA. Cerebral arteriography was done infrequently in patients with stroke in the pres ence of AF or other obvious source of emboli. General post-mortem examinations were made in 40% of dece dents; the brain was examined in half of those autbpsied. In addition to noting the presence of AF on ECG during biennial exam, AF was sought during review of all interim hospitalizations. Duration of AF was meas ured from the time of first documentation by ECG available for review. AF was often documented for the first time at the time of admission for stroke. In those instances no judgement as to the short term duration of AF could be made. Anticoagulants were not in use to any significant extent in this group either at time of onset or recurrence.
Since it is often not possible to distinguish thrombot ic from embolic stroke all strokes occurring in persons with AF were counted without respect to probable stroke mechanisms. Analyses relating AF to stroke was restricted to persons with AF unassociated with RHD. CHF and CHD are frequent precursors of stroke with or without AF. To determine the additional role of AF as a risk factor for stroke, a multiple logistic regres sion was performed. The variables age, CHD, CHF, Since AF often occurs in persons with stroke-induc ing impaired cardiac function, notably congestive heart failure and coronary heart disease and is directly related to age and systolic blood pressure, a multivar iate logistic analysis including these variables and AF Was done (table 2). Each of the variables are signifi cantly related to stroke incidence and each makes a contribution that is independent of the other factors. Not only does AF make a contribution to stroke risk that is independent of coronary heart failure and coro nary heart disease, the size of the coefficient, (beta), for AF is also greater than for either of these variables showing AF to be at least as powerful as these three cofactors.
When distribution of cases of stroke is examined in relation to duration of AF prior to stroke a clustering close to onset of AF is seen ( fig. 1) . Nearly a quarter, 14 of 59, had AF noted for the first time during hospi talization for stroke. An additional eight cases (14%) occurred in the first twelve months following the onset of AF. Thereafter, stroke occurred at about 5% per year. 
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Discussion
The presence of AF poses a vexing clinical problem for both the cardiologist and the neurologist. The gen eral impression has been that AF is linked to Stroke only in patients with valvular or RHD. 6 Many physi cians, generally on the basis of personal experience and reports in the early cardiology literature, believe chronic AF to be benign and are reluctant to prescribe medication to prevent the seemingly rare complication of stroke. 7 ' 8 There is even less enthusiasm to utilize a potentially hazardous or lethal therapy, chronic anti coagulation, in elderly patients who are susceptible to many of the complications of this therapy.
Once reasonable estimates of the risks of stroke in In the present report, 12% of initial strokes in this general population sample occurred in the presence of AF without valvu lar heart disease. Since AF incidence rises with age its contribution to stroke occurrence can be expected to rise in the United States, as it will in this cohort as it ages.
Onset of AF is clearly temporally related to immi nence of stroke. AF is present at the time of stroke onset in 24% and within six months of onset in about a third of AF associated strokes. Patients with recent onset of AF are certainly at high risk and warrant vigorous preventive measures. AF commonly follows the development of overt cardiovascular disease par ticularly congestive heart failure and hypertensive car diovascular disease and prevention of these conditions may be the best prophylaxis for AF. Even in the pres ence of hypertension, congestive failure, and coronary heart disease, AF makes a significant independent con tribution to stroke incidence. Recurrence, like initial onset, seems to cluster in the early months again en couraging prompt and vigorous efforts be made if stroke is to be prevented.
In a surgical series of patients recuperating from peripheral arterial embolectomy, recurrence was com mon, 50% sustained at least one recurrence, and oc curred soon after the initial embolism. 15 Among those patients with nonrheumatic AF as the source, recur rence occurred within four days in 26%, within two weeks in 47%, and within four mohths in 68%.
There is reason to believe the bulk of strokes occur ring in persons with AF are on the basis of cerebral embolism, although AF does reduce cerebral blood flow and could thereby contribute to stroke. [13] [14] [15] [16] Efforts at stroke prevention in patients with nonvalvular AF undoubtedly will rest in therapies that interfere with intra-atrial thrombus formation. A controlled trial of antithrombotic agents or anticoagulants for stroke pre vention in nonrheumatic AF and particularly in recent onset AF seems long overdue.
